Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
Since acquiring rare disease specialist Horizon Therapeutics for $27.8 billion in 2023, Amgen has struggled…
Neurocrine Biosciences, forever a potential M&A target in the biopharmaceutical industry, has made major acquisitions…
VML Health urges marketers to move from longevity to ‘periods of joy’ as patient goals evolve
By healthadmin
VML Health releases a report on 10 trends that will define the future of healthcare,…
To commemorate its 150th anniversary and the arrival of a college basketball star in his…
With Sanofi-Pfizer deal, Novavax bets on ‘amplification strategy’ to power vaccine engine
By healthadmin
Novavax began an identity shift in 2023, moving away from the fully integrated business ambitions…
7 deals worth more than $1 billion in 12 days, raising expectations for biopharmaceutical M&A
By healthadmin
Forget about March going out like a lamb. March was a great month for M&A.…
After a series of high-profile pledges to bring drug manufacturing back to the United States,…
Fierce Pharma Asia—President Trump’s 100% drug tariffs. Takeda Pharmaceutical is reducing its workforce. Lilly, Insilico AI Trading
By healthadmin
The United States will impose 100% tariffs on pharmaceutical imports, with some exceptions. Takeda Pharmaceutical…
President Trump imposes 100% tariffs on imported medicines, but leaves many exceptions
By healthadmin
For more than a year, the biopharmaceutical industry has had to quickly respond to various…
BioNTech is turning off the lights at its Singapore factory and planned regional headquarters, which…